124 related articles for article (PubMed ID: 38515328)
21. First Report of Powdery Mildew Caused by Golovinomyces magnicellulatus var. magnicellulatus on Physalis alkekengi var. franchetii in China.
Liang C; Xing HH; Liu Z; Cho SE; Shin HD
Plant Dis; 2013 Oct; 97(10):1382. PubMed ID: 30722154
[TBL] [Abstract][Full Text] [Related]
22. Systems pharmacology reveals the mechanism of activity of Physalis alkekengi L. var. franchetii against lipopolysaccharide-induced acute lung injury.
Yang Y; Ding Z; Wang Y; Zhong R; Feng Y; Xia T; Xie Y; Yang B; Sun X; Shu Z
J Cell Mol Med; 2020 May; 24(9):5039-5056. PubMed ID: 32220053
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of proteins in the extracts of Physalis alkekengi L. var. franchetii (Mast.) Makino using nanoflow reversed-phase liquid chromatography-tandem mass spectrometry].
Yu H; Yan J; Guo M; Jin Y
Se Pu; 2013 Apr; 31(4):362-6. PubMed ID: 23898636
[TBL] [Abstract][Full Text] [Related]
24. Physakengoses K-Q, seven new sucrose esters from Physalis alkekengi var. franchetii.
Zhang CY; Luo JG; Liu RH; Lin R; Yang MH; Kong LY
Carbohydr Res; 2017 Sep; 449():120-124. PubMed ID: 28779658
[TBL] [Abstract][Full Text] [Related]
25. Physalis alkekengi L. var. franchetii combined with hormone therapy for atopic dermatitis.
Yang M; Zhao M; Xia T; Chen Y; Li W; Zhang H; Peng M; Li C; Cao X; Liang L; Yue Y; Zhong L; Du J; Li J; Wang Y; Shu Z
Biomed Pharmacother; 2023 Jun; 162():114622. PubMed ID: 37003035
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic analyses reveal antiinflammatory mechanism of withanolides derived from the fruits of Physalis alkekengi L. var. franchetii.
Wang CF; Xu WJ; Xu Y; Wang YX; Liu JQ
Phytother Res; 2021 May; 35(5):2568-2578. PubMed ID: 33350549
[TBL] [Abstract][Full Text] [Related]
27. Non-targeted chromatographic analyses of cuticular wax flavonoids from Physalis alkekengi L.
Kranjc E; Albreht A; Vovk I; Makuc D; Plavec J
J Chromatogr A; 2016 Mar; 1437():95-106. PubMed ID: 26875116
[TBL] [Abstract][Full Text] [Related]
28. Steroids and flavonoids from Physalis alkekengi var. franchetii and their inhibitory effects on nitric oxide production.
Qiu L; Zhao F; Jiang ZH; Chen LX; Zhao Q; Liu HX; Yao XS; Qiu F
J Nat Prod; 2008 Apr; 71(4):642-6. PubMed ID: 18348534
[TBL] [Abstract][Full Text] [Related]
29. Anti-hyperglycemic activity of polysaccharides from calyx of Physalis alkekengi var. franchetii Makino on alloxan-induced mice.
Guo Y; Li S; Li J; Ren Z; Chen F; Wang X
Int J Biol Macromol; 2017 Jun; 99():249-257. PubMed ID: 28238911
[TBL] [Abstract][Full Text] [Related]
30. A pair of 3-epimeric physalins from Physalis alkekengi L. var. franchetii.
Qiu L; Jiang ZH; Liu HX; Chen LX; Yao XS; Qiu F
J Asian Nat Prod Res; 2008; 10(9-10):881-5. PubMed ID: 18985501
[TBL] [Abstract][Full Text] [Related]
31. The alleviative effect of flavonol-type Nrf2 activator rhamnazin from Physalis alkekengi L. var. franchetii (Mast.) Makino on pulmonary disorders.
Wu XY; Wang T; Hu HX; Zhang K; Zhao Y; Zhao BB; Lou HX; Wang XN; Shen T
Phytother Res; 2022 Apr; 36(4):1692-1707. PubMed ID: 35129872
[TBL] [Abstract][Full Text] [Related]
32. Identification of absorbed constituents and in vivo metabolites in rats after oral administration of Physalis alkekengi var. franchetii by ultra-high-pressure liquid chromatography quadrupole time-of-flight mass spectrometry.
Feng X; Huo X; Liu H; Chai L; Ding L; Qiu F
Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29055030
[TBL] [Abstract][Full Text] [Related]
33. [The potential antineoplastic acting constituents of Physalis alkekengi L. var franchetii Mast].
Dornberger K
Pharmazie; 1986 Apr; 41(4):265-8. PubMed ID: 3725872
[TBL] [Abstract][Full Text] [Related]
34. Metabolite Profiling, through LC-ESI/LTQOrbitrap/MS Analysis, of Antioxidant Extracts from
Crescenzi MA; Serreli G; Deiana M; Tuberoso CIG; Montoro P; Piacente S
Antioxidants (Basel); 2023 Dec; 12(12):. PubMed ID: 38136220
[TBL] [Abstract][Full Text] [Related]
35. Calystegins of Physalis alkekengi var. francheti (Solanaceae). Structure determination and their glycosidase inhibitory activities.
Asano N; Kato A; Oseki K; Kizu H; Matsui K
Eur J Biochem; 1995 Apr; 229(2):369-76. PubMed ID: 7744059
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activity of the extracts and physalin D from Physalis alkekengi and evaluation of antioxidant potential of physalin D.
Helvaci S; Kökdil G; Kawai M; Duran N; Duran G; Güvenç A
Pharm Biol; 2010 Feb; 48(2):142-50. PubMed ID: 20645830
[TBL] [Abstract][Full Text] [Related]
37. Characterization of physalins and fingerprint analysis for the quality evaluation of Physalis alkekengi L. var. franchetii by ultra-performance liquid chromatography combined with diode array detection and electrospray ionization tandem mass spectrometry.
Zheng Y; Luan L; Chen Y; Ren Y; Wu Y
J Pharm Biomed Anal; 2012 Dec; 71():54-62. PubMed ID: 22964457
[TBL] [Abstract][Full Text] [Related]
38. Effects of polysaccharide from Physalis alkekengi var. francheti on liver injury and intestinal microflora in type-2 diabetic mice.
Zhao X; Chen Z; Yin Y; Li X
Pharm Biol; 2017 Dec; 55(1):2020-2025. PubMed ID: 28832229
[TBL] [Abstract][Full Text] [Related]
39. Physalins with anti-inflammatory activity are present in Physalis alkekengi var. franchetii and can function as Michael reaction acceptors.
Ji L; Yuan Y; Luo L; Chen Z; Ma X; Ma Z; Cheng L
Steroids; 2012 Apr; 77(5):441-7. PubMed ID: 22197662
[TBL] [Abstract][Full Text] [Related]
40. Quantitative and transformation product analysis of major active physalins from Physalis alkekengi var. franchetii (Chinese lantern) using ultraperformance liquid chromatography with electrospray ionisation tandem mass spectrometry and time-of-flight mass spectrometry.
Zheng Y; Chen Y; Ren Y; Luan L; Wu Y
Phytochem Anal; 2012; 23(4):337-44. PubMed ID: 21997776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
